Retatrutide, developed by Soma, represents a promising breakthrough in weight control . This dual-action compound combines incretin receptor agonist properties with another receptor stimulation , indicating remarkable results in clinical findings for weight reduction . Scientists believe Retatrutide could provide a different pathway for people stru